Nuzenio

Travere Therapeutics

Travere Therapeutics news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 24 latest news signals 14 publisher sources 100/100 entity strength

Latest news

TVTX Stock Slides 6% On Everest Deal, Erases Some Losses As Analyst Sees 49% Upside - StocktwitsStocktwits · Sat, 08 Aug 2026 10:43:58 GMTTravere Therapeutics Reports First Quarter 2026 Financial Results - The National Law ReviewThe National Law Review · Sat, 08 Aug 2026 08:07:57 GMTState Street Corporation (TVTX) discloses 4.6% beneficial stake in Travere - Stock TitanStock Titan · Fri, 07 Aug 2026 15:04:08 GMTTravere Therapeutics (TVTX) Gets a Buy from Wells Fargo - The Globe and MailThe Globe and Mail · Fri, 07 Aug 2026 11:30:00 GMTWhy Travere Therapeutics (TVTX) Is Up 9.0% After FILSPARI-Driven Q2 Revenue Jump And Wider Loss - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 07:11:19 GMTTravere Therapeutics Wins Much-Awaited Approval For Drug In Rare Kidney Disease - StocktwitsStocktwits · Fri, 07 Aug 2026 05:35:02 GMTTVTX, LGND Stocks In Spotlight Ahead Of Monday’s FDA Call On Kidney Drug Filspari - StocktwitsStocktwits · Fri, 07 Aug 2026 04:36:10 GMTTravere Therapeutics (TVTX) On Q2 Results And FILSPARI Hopes As Fair Value Stays In View - Yahoo Finance SingaporeYahoo Finance Singapore · Fri, 07 Aug 2026 04:29:00 GMT

Timeline

Sat, 08 Aug 2026 10:43:58 GMTTVTX Stock Slides 6% On Everest Deal, Erases Some Losses As Analyst Sees 49% Upside - Stocktwits
Sat, 08 Aug 2026 08:07:57 GMTTravere Therapeutics Reports First Quarter 2026 Financial Results - The National Law Review
Fri, 07 Aug 2026 15:04:08 GMTState Street Corporation (TVTX) discloses 4.6% beneficial stake in Travere - Stock Titan
Fri, 07 Aug 2026 11:30:00 GMTTravere Therapeutics (TVTX) Gets a Buy from Wells Fargo - The Globe and Mail
Fri, 07 Aug 2026 07:11:19 GMTWhy Travere Therapeutics (TVTX) Is Up 9.0% After FILSPARI-Driven Q2 Revenue Jump And Wider Loss - Yahoo Finance
Fri, 07 Aug 2026 05:35:02 GMTTravere Therapeutics Wins Much-Awaited Approval For Drug In Rare Kidney Disease - Stocktwits

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.PoliticsPolitics stories explain decisions, institutions, parties, leaders, laws, budgets, elections, courts, and public accountability.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Travere Therapeutics.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

14 distinct publisher/source names are currently connected to this entity page.